Bushnell P J, Padilla S S, Ward T, Pope C N, Olszyk V B
Neurotoxicology Division, United States Environmental Protection Agency, Research Triangle Park, North Carolina.
J Pharmacol Exp Ther. 1991 Feb;256(2):741-50.
Behavioral effects of organophosphates (OPs) typically decrease with repeated exposure, despite persistence of OP-induced inhibition of acetylcholinesterase (AChE) and downregulation of muscarinic acetylcholine (ACh) receptors. To characterize this tolerance phenomenon, rats were trained to perform an appetitive operant task which allowed daily quantification of working memory (accuracy of delayed matching-to-position), reference memory (accuracy of visual discrimination) and motor function (choice response latencies and inter-response times during delay). Daily s.c. injections of 0.2 mg/kg of diisopropylfluorophosphate (DFP) caused no visible cholinergic signs, did not affect body weight or visual discrimination, but progressively impaired matching accuracy and lengthened response latencies and interresponse times. These effects recovered in seven of eight treated rats after termination of DFP treatment. Resumption of daily DFP at 0.1 mg/kg caused smaller impairments of both matching accuracy and response latency. After 21 injections of 0.2 mg/kg/day of DFP, rats were subsensitive to the hypothermia induced by acute oxotremorine (0.2 mg/kg i.p.), as expected after OP-induced downregulation of muscarinic ACh receptors. Evidence for supersensitivity to scopolamine (0.03 and 0.056 mg/kg i.p.) in DFP-treated rats was mixed, with additive effects predominating on both the cognitive and motor aspects of the task. After 18 days of 0.1 mg/kg of DFP, AChE was inhibited 50 to 75% and muscarinic ACh receptor density was reduced 15 to 20% in hippocampus and frontal cortex. Progressive declines in AChE activity in hippocampus and frontal cortex across 15 daily doses with DFP at 0.1 and 0.2 mg/kg were observed in other rats; quinuclidinyl benzilate binding was significantly reduced in hippocampus after 15 doses at both levels of DFP. These results indicate that animals showing a definitive sign of tolerance to OP administration (subsensitivity to a cholinergic agonist) were also functionally impaired on both the mnemonic and motoric demands of a working memory task. The nature of this impairment suggests further that it results from compensatory changes in the central nervous system, e.g., muscarinic receptor downregulation, considered to produce "tolerance" to OPs in exposed animals.
有机磷酸酯(OPs)的行为效应通常会随着反复接触而减弱,尽管OPs诱导的乙酰胆碱酯酶(AChE)抑制作用持续存在,且毒蕈碱型乙酰胆碱(ACh)受体下调。为了描述这种耐受现象,对大鼠进行训练以执行一项操作性食欲任务,该任务允许每日定量评估工作记忆(延迟位置匹配的准确性)、参考记忆(视觉辨别准确性)和运动功能(延迟期间的选择反应潜伏期和反应间隔时间)。每天皮下注射0.2mg/kg的二异丙基氟磷酸酯(DFP)未引起明显的胆碱能体征,不影响体重或视觉辨别,但逐渐损害匹配准确性,并延长反应潜伏期和反应间隔时间。在DFP治疗终止后,8只接受治疗的大鼠中有7只的这些效应恢复。恢复每天注射0.1mg/kg的DFP导致匹配准确性和反应潜伏期的损害较小。在每天注射0.2mg/kg的DFP共21次后,大鼠对急性氧化震颤素(0.2mg/kg腹腔注射)诱导的体温过低反应不敏感,这正如OPs诱导毒蕈碱型ACh受体下调后所预期的那样。DFP处理的大鼠对东莨菪碱(0.03和0.056mg/kg腹腔注射)超敏反应的证据不一,在任务的认知和运动方面,相加效应占主导。在注射0.1mg/kg的DFP 18天后,海马体和额叶皮质中的AChE被抑制50%至75%,毒蕈碱型ACh受体密度降低15%至20%。在其他大鼠中,观察到在每天注射0.1mg/kg和0.2mg/kg的DFP共15次剂量后,海马体和额叶皮质中的AChE活性逐渐下降;在两种DFP剂量水平下注射15次后,海马体中的奎宁环基苯甲酸酯结合显著减少。这些结果表明,对OP给药表现出明确耐受迹象(对胆碱能激动剂反应不敏感)的动物在工作记忆任务的记忆和运动需求方面也存在功能受损。这种损害的性质进一步表明,它是由中枢神经系统的代偿性变化引起的,例如毒蕈碱受体下调,这被认为会使暴露动物对OPs产生“耐受”。